ReviewFrontiers in molecular biosciences2026
Single-cell transcriptomics of granulocytes in asthma and atopic diseases.
Review in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since their early association with atopic disease, granulocytes, particularly eosinophils, have been widely used as biomarkers, yet the mechanisms underlying their role in airway and atopic inflammatory diseases remain incompletely understood. Single-cell transcriptomic approaches have begun to reveal substantial phenotypical and functional heterogeneity among granulocytes such as neutrophils and eosinophils, as well as in mast cells. In contrast, basophils remain sparsely represented in current datasets. As studies of other immune lineages have shown the significance of cellular diversity in atopic disease, extending this resolution to granulocytes marks an important frontier. In this review, we outline the historical and technical challenges that have constrained single-cell studies of human granulocytes and highlight the methodological breakthroughs that are now overcoming these barriers. We systematically reviewed published granulocyte scRNA-seq studies using PubMed and Talk2Data (BioTuring) platform. Our review underscores emerging roles for granulocyte heterogeneity in asthma and atopic disease and identifies remaining knowledge gaps where experimental and computational advances may accelerate understanding of their pathophysiologic functions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.